Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 3/20 | 0.36 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.32 |
| ▸ | NRAS | P01111 | 1/20 | 0.31 |
| ▸ | FLT3 | P36888 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3847600 | 0.85 | TGFBR1 (0.38) | TGFBR1SCN5APIK3CANRASFLT3 | |
| Trifluoroacetic Acid SCHEMBL3856637 | 0.84 | TGFBR1 (0.36) | TGFBR1SCN5APIK3CAPIK3CBMTOR | |
| Trifluoroacetic Acid SCHEMBL3848210 | 0.83 | TGFBR1 (0.35) | TGFBR1SCN5APIK3CAPIK3CBMTOR | |
| Trifluoroacetic Acid SCHEMBL3853505 | 0.83 | MAPK1 (0.40) | TGFBR1MAPT | |
| SCHEMBL3847238 | 0.82 | TGFBR1 (0.40) | TGFBR1PIK3CAPIK3CBMTORCDK19 | |
| SCHEMBL3847144 | 0.82 | PIK3CA (0.32) | TGFBR1SCN5APIK3CAPIK3CBMTOR | |
| Hydrochloric Acid SCHEMBL3851941 | 0.81 | TGFBR1 (0.38) | TGFBR1PIK3CANRASFLT3PIK3CB | |
| SCHEMBL3846083 | 0.81 | TGFBR1 (0.38) | TGFBR1PIK3CANRASFLT3 | |
| Trifluoroacetic Acid SCHEMBL3857703 | 0.81 | ABL1 (0.37) | TGFBR1SCN5APIK3CAPIK3CBMTOR | |
| Hydrochloric Acid SCHEMBL3845315 | 0.81 | TGFBR1 (0.37) | TGFBR1PIK3CANRASFLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2048142-A2 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | Eisai R&D Management Co., Ltd. (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-1382603-B1 | NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | EISAI R&D MAN CO LTD (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-7074801-B1 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | EISAI CO., LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-1382603-A1 | NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | Eisai Co., Ltd. (JP) | 2004-01-21 | — | — | EP | disclosed |